PM
ADMA icon

Prosight Management’s ADMA Biologics ADMA Stock Holding History

Prosight Management’s Portfolio ADMA Stock Details ADMA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-115,100
Closed -$184K – 44
2021
Q2 		$184K Sell
115,100
-382,742
-77% -$673K 0.12% 46
2021
Q1 		$876K Sell
497,842
-385,372
-44% -$882K 0.72% 30
2020
Q4 		$1.72M Buy
883,214
+347,890
+65% +$731K 0.87% 28
2020
Q3 		$1.28M Sell
535,324
-763,976
-59% -$2.09M 0.63% 38
2020
Q2 		$3.81M Buy
1,299,300
+56,600
+5% +$163K 1.89% 22
2020
Q1 		$3.58M Buy
+1,242,700
New +$4.3M 1.68% 21
2019
Q4 		– Sell
-548,409
Closed -$2.44M – 40
2019
Q3 		$2.44M Buy
548,409
+362,688
+195% +$1.52M 1.36% 25
2019
Q2 		$719K Buy
+185,721
New +$820K 0.37% 34

Other funds holding ADMA

PA
Perceptive Advisors New York $5.06B AUM 314.02% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFM
Boothbay Fund Management New York $4.34B AUM 106.31% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $77.3B AUM 36.07% 1-Year Est. Return
MF
Magnetar Financial Evanston, Illinois $9.83B AUM 190.64% 1-Year Est. Return
CC
Clearline Capital New York $1.29B AUM 38.13% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return